ASND
Ascendis Pharma (ASND) Investor Questions
Review Ascendis Pharma (ASND) faq with company data, supporting context and links to related investor research.
Research record updated: . Individual measures may refer to different reporting periods.
- Company
- Ascendis Pharma
- Sector
- Healthcare
- Industry
- Biotechnology
- Overall BTI score
- 85
- Annual revenue
- $826.51M
- Annual net income
- $-261.72M
- Annual free cash flow
- $50.06M
Ascendis Pharma (ASND) Investor Questions research
Ascendis Pharma trades under the ticker ASND. The company is classified in the Healthcare sector and the Biotechnology industry.
Investors commonly review ASND through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. Use the financial statements to check whether reported profit is supported by cash generation.